Assignee
MTHERA PHARMA CO LTD
KR·0 granted patents·5 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
5 records- 0165US2024342235A1Composition for treating inflammatory bowel disease, comprising combined extract of isatidis folium and juglans mandshuricaMTHERA PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0263US2024325469A1Composition for prevention or treatment of cognitive dysfunction and intestinal dysfunction, comprising lactobacillus paracasei nk112, cuscuta australis extract, and cuscuta japonica extractMTHERA PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0359US2023414689A1Composition for preventing, improving or treating inflammatory bowel disease, comprising isatidis folium extractMTHERA PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0459US2024024402A1Composition for improving insulin sensitivity, containing gentiana trifloral pallas extractMTHERA PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0549US2023263852A1Composition For Preventing Or Treating Neurodegenerative Diseases Containing Mixed Herbal Extract Of Genkwae Flos, Clematidis Radix, And Gastrodiae RhizomaMTHERA PHARMA CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MTHERA PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →